Skip to main content
. 2024 Jul 2;25(13):7271. doi: 10.3390/ijms25137271

Table 1.

Similarities and differences between Alzheimer’s disease and age-related macular degeneration.

Characteristics Alzheimer’s Disease Age-Related Macular Degeneration
Risk factors aging, genetic susceptibility, female sex, atherosclerosis, hypertension, diabetes, obesity, unhealthy diet, smoking, sleep disturbances, traumatic brain injury, social isolation aging, genetic susceptibility, female sex, atherosclerosis, hypertension, diabetes, obesity, unhealthy diet, smoking, UV light, obstructive sleep apnea, sleep disturbances
Histopathological findings senile plaques: extracellular Aβ deposits
neurofibrillary tangles: intracellular accumulation of p-Tau protein and vitronectin
drusen: focal extracellular deposits, accumulate between the RPE and Bruch’s membrane
containing Aβ, clusterin, vitronectin, amyloid P, apolipoprotein E, complement regulatory proteins, and inflammatory mediators
Aβ protein the main component of senile plaques component of subretinal drusen
p-Tau deposits component of neurofibrillary tangles mildly increased in the RPE
Oxidative and metabolic
stress
associated with mental deficiencies and neuronal damage associated with visual cycle and drusen formation
Glial reactivity astrocytes and microglia around senile plaques microglia in the subretinal space and surrounding the drusen
Non-visual disturbances cognitive deficits (memory loss, aphasia, apraxia, agnosia),
depression, behavioral disturbances,
inability for self-care
decreased verbal fluency and verbal memory,
reduced visuospatial processing and attention,
cognitive decline, higher risk of dementia
Cause of visual disturbances the loss of GCC photoreceptor layer damage
Location of retinal damage GCC, RNFL RPE, photoreceptors
Location of brain damage atrophy of brain frontal, temporal, and parietal lobes, entorhinal cortex, amygdala, and hippocampus optic tract volume reduction
loss of cerebral white matter connectivity in areas responsible for verbal fluency and memory
Diagnostic procedures clinical examination,
neuropsychological testing
CSF sampling
brain imaging: MRI, fMRI, CT
PET-CR, amyloid imaging
ophthalmological examination
OCT, OCTA
FA, ICGA
OCT findings reduced GCC, GC-IPL, peripapillary RNFL nonexudative AMD: drusen under the RPE, PED
exudative AMD: subretinal fluid, CNV
Pleiotropic genes APOC1–increased risk
APOE2 allele–reduced risk
APOE4 allele–increased risk
APOC1–increased risk
APOE2 allele–increased risk
APOE4 allele–reduced risk

UV: ultraviolet; Aβ: amyloid β; p-Tau: hyperphosphorylated tau; RPE: retinal pigment epithelium; GCC: ganglion cell complex; RNFL: retinal nerve fiber layer; MRI: magnetic resonance imaging; fMRI: functional MRI; CT: computed tomography; PET: positron emission tomography; CSF: cerebrospinal fluid; OCT: optical coherent tomography; OCTA: OCT angiography; FA: fluorescein angiography; ICGA: indocyanine green angiography; GC-IPL: macular ganglion cell-inner plexiform layer; PED: pigment epithelial detachment; CNV: choroidal neovascularization; APOC1: Apolipoprotein C-1 gene; APOE: Apolipoprotein E gene.